Sun Pharma shares rise as USFDA clears Mohali facility
Sun Pharma said, “It's subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status."
Sun Pharma shares closed at Rs 708.25 per piece on BSE, up Rs 24 or 3.61%. Photo: Reuters